Ranbaxy returns to profit in Q2 on robust volumes

Drug firm Ranbaxy Laboratories on Monday reported a consolidated net profit of Rs 477.75 crore (Rs 4.77 billion)for the quarter ended September 30, 2014 on account of robust sales. The company had......

Ranbaxy shares jump on drug approval in US

Shares of Ranbaxy Laboratories rose more than 5 per cent after the company announced a US regulatory approval for a hypertension drug to be launched by one of its subsidiaries. The stock rose by......

Ranbaxy gets FDA nod to sell generic Diovan tablets in US

Drug major Ranbaxy Laboratories has received US health regulator's approval to market generic version of Novartis' Diovan tablets, used for treating high blood pressure and heart failure, in the US......

Sensex ends below 27,000; ITC, ICICI Bank dip 2%

B Markets extended losses on Wednesday and the Sensex ended below 27,000 for the second straight session weighed down by select index heavyweights even as oil and gas shares rebounded from their......